Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Renal Failure

  Free Subscription


Articles published in J Am Soc Nephrol

Retrieve available abstracts of 65 articles:
HTML format



Single Articles


    November 2022
  1. GINSBERG C, Miller LM, Ofsthun N, Dalrymple LS, et al
    Differences in Phosphate and Parathyroid Hormone Concentrations over the Day among Patients on Hemodialysis.
    J Am Soc Nephrol. 2022;33:2087-2093.
    PubMed     Abstract available


    October 2022
  2. VERBITSKY M, Krishnamurthy S, Krithivasan P, Hughes D, et al
    Genomic Disorders in Chronic Kidney Disease Across the Lifespan.
    J Am Soc Nephrol. 2022 Oct 27. pii: ASN.2022060725. doi: 10.1681/ASN.2022060725.
    PubMed     Abstract available


  3. SHUKLA A, Cavanaugh K, Wadhwa A, Crowley S, et al
    Basic Requirements for Improving Home Dialysis Utilization: Specialty Nephrology Care and Pre-End Stage Kidney Disease Education.
    J Am Soc Nephrol. 2022 Oct 25. pii: ASN.2022060685. doi: 10.1681/ASN.2022060685.
    PubMed    


  4. TUMMALAPALLI SL, Lin E
    Is Home Dialysis the Way Forward for Medicare? Assessing Potential Cost Savings Associated with Peritoneal Dialysis.
    J Am Soc Nephrol. 2022 Oct 12. pii: ASN.2022091017. doi: 10.1681/ASN.2022091017.
    PubMed    


    September 2022
  5. BISSONNETTE MLZ, Riazy M, Cunningham AM, Gill JS, et al
    A Step toward Understanding the Story Behind the Pictures: Molecular Diagnostics and the Banff Classification of Renal Allograft Pathology.
    J Am Soc Nephrol. 2022 Sep 28. pii: ASN.2022070847. doi: 10.1681/ASN.2022070847.
    PubMed    


  6. BUTLER CR, Wachterman MW, O'Hare AM
    Concurrent Hospice and Dialysis: Proof of Concept.
    J Am Soc Nephrol. 2022 Sep 12. pii: ASN.2022080919. doi: 10.1681/ASN.2022080919.
    PubMed    


    August 2022
  7. ROSTOKER G, Issad B
    Financial Barriers to the Optimal Use of Peritoneal Dialysis in France and Europe, as in the United States.
    J Am Soc Nephrol. 2022 Aug 30. pii: ASN.2022070839. doi: 10.1681/ASN.2022070839.
    PubMed    


  8. BERGLING K, Martus G, Oberg C
    Phloretin Improves Ultrafiltration and Reduces Glucose Absorption during Peritoneal Dialysis in Rats.
    J Am Soc Nephrol. 2022 Aug 19. pii: ASN.2022040474. doi: 10.1681/ASN.2022040474.
    PubMed     Abstract available


  9. HOLLE J, Bartolomaeus H, Lober U, Behrens F, et al
    Inflammation in Children with Chronic Kidney Disease Linked to Gut Dysbiosis and Metabolite Imbalance.
    J Am Soc Nephrol. 2022 Aug 19. pii: ASN.2022030378. doi: 10.1681/ASN.2022030378.
    PubMed     Abstract available


  10. KAPLAN JM, Niu J, Ho V, Winkelmayer WC, et al
    A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis.
    J Am Soc Nephrol. 2022 Aug 18. pii: ASN.2022020221. doi: 10.1681/ASN.2022020221.
    PubMed     Abstract available


  11. JONGS N, Chertow G, Greene T, McMurray J, et al
    Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Aug 17. pii: ASN.2022030306. doi: 10.1681/ASN.2022030306.
    PubMed     Abstract available


  12. MONTEZ-RATH ME, Garcia P, Han J, Cadden L, et al
    SARS-CoV-2 Infection during the Omicron Surge among Patients Receiving Dialysis: The Role of Circulating Receptor-Binding Domain Antibodies and Vaccine Doses.
    J Am Soc Nephrol. 2022 Aug 16. pii: ASN.2022040504. doi: 10.1681/ASN.2022040504.
    PubMed     Abstract available


  13. MALIHA G, Glickman JD, McCoy MS
    Ensuring Equitable Access to Dialysis: The Medicare Secondary Payer Act in Marietta Memorial Hospital Employee Health Benefit Plan v. DaVita, Inc.
    J Am Soc Nephrol. 2022 Aug 3. pii: ASN.2022020224. doi: 10.1681/ASN.2022020224.
    PubMed    


    July 2022
  14. TERKER A, Saritas T, McDonough A
    The Highs and Lows of Potassium Intake in Chronic Kidney Disease - Does One Size Fit All?
    J Am Soc Nephrol. 2022 Jul 19. pii: ASN.2022070743. doi: 10.1681/ASN.2022070743.
    PubMed    


  15. BARRACLOUGH KA, McAlister S
    Assessing the Carbon Footprint of Hemodialysis: A First Step Toward Environmentally Sustainable Kidney Care.
    J Am Soc Nephrol. 2022 Jul 15. pii: ASN.2022060661. doi: 10.1681/ASN.2022060661.
    PubMed    


  16. BLUM MF, Feng Y, Anderson GB, Segev DL, et al
    Hurricanes and Mortality among Patients Receiving Dialysis.
    J Am Soc Nephrol. 2022 Jul 14. pii: ASN.2021111520. doi: 10.1681/ASN.2021111520.
    PubMed     Abstract available


  17. ERNECOFF N, Bursic A, Motter E, Lagnese K, et al
    Description and Outcomes of an Innovative Concurrent Hospice-Dialysis Program.
    J Am Soc Nephrol. 2022 Jul 12. pii: ASN.2022010064. doi: 10.1681/ASN.2022010064.
    PubMed     Abstract available


  18. RICHERSON WT, Schmit BD, Wolfgram DF
    The Relationship between Cerebrovascular Reactivity and Cerebral Oxygenation During Hemodialysis.
    J Am Soc Nephrol. 2022 Jul 1. pii: ASN.2021101353. doi: 10.1681/ASN.2021101353.
    PubMed     Abstract available


  19. LASTER M, Norris KC
    Equitable Transplantation: A Modifiable Risk Factor for Disparities in Mortality in ESKD.
    J Am Soc Nephrol. 2022;33:1240-1241.
    PubMed    


  20. BECERRA AZ, Chan KE, Eggers PW, Norton J, et al
    Transplantation Mediates Much of the Racial Disparity in Survival from Childhood-Onset Kidney Failure.
    J Am Soc Nephrol. 2022;33:1265-1275.
    PubMed     Abstract available


    June 2022
  21. SILBERZWEIG J, Bhat JG, Dittrich M, Durvasula R, et al
    Collaboration between Dialysis Providers and the American Society of Nephrology: Dialysis in the COVID Pandemic.
    J Am Soc Nephrol. 2022 Jun 2. pii: ASN.2021111475. doi: 10.1681/ASN.2021111475.
    PubMed    


  22. SEHGAL A, Slutzman J, Huml A
    Sources of Variation in the Carbon Footprint of Hemodialysis Treatment.
    J Am Soc Nephrol. 2022 Jun 2. pii: ASN.2022010086. doi: 10.1681/ASN.2022010086.
    PubMed     Abstract available


  23. YUN HR, Joo YS, Kim HW, Park JT, et al
    Coronary Artery Calcification Score and the Progression of Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Jun 2. pii: ASN.2022010080. doi: 10.1681/ASN.2022010080.
    PubMed     Abstract available


  24. QUINN RR, Lam NN, Ravani P, Oliver MJ, et al
    The Advancing American Kidney Health Initiative: The Challenge of Measuring Success.
    J Am Soc Nephrol. 2022;33:1060-1062.
    PubMed    


    May 2022
  25. GRITTER M, Wouda R, Yeung S, Wieers M, et al
    Effects of Short-Term Potassium Chloride Supplementation in Patients with Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 May 24. pii: ASN.2022020147. doi: 10.1681/ASN.2022020147.
    PubMed     Abstract available


  26. PEREZ L, Biruete A
    Lack of Cultural and Language Concordant Nutrition Education for Hispanic/Latinx Individuals with Chronic Kidney Disease: A Call to Action.
    J Am Soc Nephrol. 2022 May 11. pii: ASN.2022040430. doi: 10.1681/ASN.2022040430.
    PubMed    


  27. OKA Y, Miyazaki M, Takatsu S, Matsuda H, et al
    Calcium-Based Phosphate Binders and Plasma Oxalate Concentration in Dialysis Patients.
    J Am Soc Nephrol. 2022 May 2. pii: ASN.2022030248. doi: 10.1681/ASN.2022030248.
    PubMed    


  28. PFAU A, Knauf F
    Authors' Reply: Calcium-Based Phosphate Binders and Plasma Oxalate Concentration in Dialysis Patients.
    J Am Soc Nephrol. 2022 May 2. pii: ASN.2022030359. doi: 10.1681/ASN.2022030359.
    PubMed    


    April 2022
  29. RIZZOLO K, Cervantes L, Shen J
    Racial and Ethnic Disparities in Home Dialysis Use in the United States: Barriers and Solutions.
    J Am Soc Nephrol. 2022 Apr 19. pii: ASN.2022030288. doi: 10.1681/ASN.2022030288.
    PubMed    


  30. PROVENZANO M, Puchades M, Garofalo C, Jongs N, et al
    Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-over Clinical Trial.
    J Am Soc Nephrol. 2022 Apr 19. pii: ASN.2022020207. doi: 10.1681/ASN.2022020207.
    PubMed     Abstract available


  31. FISHBANE S, Pollock CA, El-Shahawy M, Escudero ET, et al
    Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.
    J Am Soc Nephrol. 2022;33:850-866.
    PubMed     Abstract available


  32. LOCATELLI F, Del Vecchio L
    The Search for the Perfect Agent for Anemia Management in Chronic Kidney Disease.
    J Am Soc Nephrol. 2022;33:662-664.
    PubMed    


    March 2022
  33. SHANKAR S, Beckett J, Tipton T, Ogbe A, et al
    SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients.
    J Am Soc Nephrol. 2022 Mar 31. pii: ASN.2021121587. doi: 10.1681/ASN.2021121587.
    PubMed    


  34. BEETHAM KS, Coombes JS, Howden EJ
    Authors' Reply: More Research is Still Needed to Support the Real-World Generalizability of the Benefits of Lifestyle Interventions for Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Mar 30. pii: ASN.2022030244. doi: 10.1681/ASN.2022030244.
    PubMed    


  35. BAERMAN EA, Kaplan J, Shen JI, Winkelmayer WC, et al
    Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States.
    J Am Soc Nephrol. 2022 Mar 21. pii: ASN.2021060854. doi: 10.1681/ASN.2021060854.
    PubMed     Abstract available


  36. VERISSIMO T, Faivre A, Rinaldi A, Lindenmeyer M, et al
    Decreased Renal Gluconeogenesis Is a Hallmark of Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Mar 10. pii: ASN.2021050680. doi: 10.1681/ASN.2021050680.
    PubMed     Abstract available


  37. OLIVER MJ, Thomas D, Balamchi S, Ip J, et al
    Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada.
    J Am Soc Nephrol. 2022 Mar 9. pii: ASN.2021091262. doi: 10.1681/ASN.2021091262.
    PubMed     Abstract available


  38. XU C, Smith E, Tiong M, Ruderman I, et al
    Interventions to Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials.
    J Am Soc Nephrol. 2022 Mar 1. pii: ASN.2021101327. doi: 10.1681/ASN.2021101327.
    PubMed     Abstract available


    February 2022
  39. VLASSCHAERT C, McNaughton A, Chong M, Cook E, et al
    Association of Clonal Hematopoiesis of Indeterminate Potential with Worse Kidney Function and Anemia in Two Cohorts of Patients with Advanced Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Feb 23. pii: ASN.2021060774. doi: 10.1681/ASN.2021060774.
    PubMed     Abstract available


  40. SAEED F, Moss A, Duberstein P, Fiscella K, et al
    Enabling Patient Choice: The "Deciding Not to Decide" Option for Older Adults Facing Dialysis Decisions.
    J Am Soc Nephrol. 2022 Feb 15. pii: ASN.2021081143. doi: 10.1681/ASN.2021081143.
    PubMed    


  41. BUNDY JD, Rahman M, Matsushita K, Jaeger BC, et al
    Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study.
    J Am Soc Nephrol. 2022 Feb 10. pii: ASN.2021060747. doi: 10.1681/ASN.2021060747.
    PubMed     Abstract available


  42. BRUNELLI S, Sibbel S, Karpinski S, Marlowe G, et al
    Comparative Effectiveness of mRNA-Based BNT162b2 Vaccine versus Adenovirus Vector-Based Ad26.COV2.S Vaccine for Prevention of COVID-19 among Dialysis Patients.
    J Am Soc Nephrol. 2022 Feb 8. pii: ASN.2021101395. doi: 10.1681/ASN.2021101395.
    PubMed     Abstract available


  43. JACOBS L, Devresse A, Baudoux T, Collart F, et al
    Confirmed Drop in Treatment of Patients with Incident End-Stage Kidney Disease During the Novel Coronavirus Disease 2019 Pandemic.
    J Am Soc Nephrol. 2022;33:455.
    PubMed    


    January 2022
  44. LEE AM, Hu J, Xu Y, Abraham AG, et al
    Using Machine Learning to Identify Metabolomic Signatures of Pediatric Chronic Kidney Disease Etiology.
    J Am Soc Nephrol. 2022 Jan 11. pii: ASN.2021040538. doi: 10.1681/ASN.2021040538.
    PubMed     Abstract available


    December 2021
  45. GUO X, Xu L, Velazquez H, Chen TM, et al
    Kidney-Targeted Renalase Agonist Prevents Cisplatin-Induced Chronic Kidney Disease by Inhibiting Regulated Necrosis and Inflammation.
    J Am Soc Nephrol. 2021 Dec 17. pii: ASN.2021040439. doi: 10.1681/ASN.2021040439.
    PubMed     Abstract available


  46. BANSAL N, Zelnick L, Reynolds K, Harrison T, et al
    Management of Adults with Newly Diagnosed Atrial Fibrillation With and Without Chronic Kidney Disease.
    J Am Soc Nephrol. 2021 Dec 17. pii: ASN.2021060744. doi: 10.1681/ASN.2021060744.
    PubMed     Abstract available


  47. FUKUMA S, Sasaki S, Taguri M, Goto R, et al
    Effect of Nudge-Based Intervention on Adherence to Physician Visit Recommendations and Early Health Outcomes among Individuals Identified with Chronic Kidney Disease in Screens.
    J Am Soc Nephrol. 2021 Dec 13. pii: ASN.2021050664. doi: 10.1681/ASN.2021050664.
    PubMed     Abstract available


  48. BEETHAM K, Krishnasamy R, Stanton T, Sacre J, et al
    Effect of a 3-Year Lifestyle Intervention in Patients with Chronic Kidney Disease: A Randomized Clinical Trial.
    J Am Soc Nephrol. 2021 Dec 10. pii: ASN.2021050668. doi: 10.1681/ASN.2021050668.
    PubMed     Abstract available


    November 2021
  49. SIBBEL S, McKeon K, Luo J, Wendt K, et al
    Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV2 Vaccines in Patients on Hemodialysis.
    J Am Soc Nephrol. 2021 Nov 17. pii: ASN.2021060778. doi: 10.1681/ASN.2021060778.
    PubMed     Abstract available


  50. THIEME CJ, Blazquez-Navarro A, Safi L, Kaliszczyk S, et al
    Impaired Humoral but Substantial Cellular Immune Response to Variants of Concern B1.1.7 and B.1.351 in Hemodialysis Patients after Vaccination with BNT162b2.
    J Am Soc Nephrol. 2021;32:2725-2727.
    PubMed    


  51. GILL JS, Schold J, Kaplan B
    Understanding Risks and Our Responsibility to Living Donors.
    J Am Soc Nephrol. 2021;32:2691-2693.
    PubMed    


    October 2021
  52. RUHL A, Jeffries N, Yang Y, Naik R, et al
    Alpha Globin Gene Copy Number is Associated with Prevalent Chronic Kidney Disease and Incident End-stage Kidney Disease among Black Americans.
    J Am Soc Nephrol. 2021 Oct 27. pii: ASN.2021050653. doi: 10.1681/ASN.2021050653.
    PubMed     Abstract available


  53. BUDDE K, Prashar R, Haller H, Rial M, et al
    Conversion from Calcineurin Inhibitor to Belatacept-based Maintenance Immunosuppression in Renal Transplant Recipients: a Randomized Phase 3b Trial.
    J Am Soc Nephrol. 2021 Oct 27. pii: ASN.2021050628. doi: 10.1681/ASN.2021050628.
    PubMed     Abstract available


  54. HORIMOTO A, Xue D, Cai J, Lash J, et al
    Genome-Wide Admixture Mapping of Estimated Glomerular Filtration Rate and Chronic Kidney Disease Identify European and African Ancestry-of-Origin Loci in Hispanic and Latino Individuals in the United States.
    J Am Soc Nephrol. 2021 Oct 20. pii: ASN.2021050617. doi: 10.1681/ASN.2021050617.
    PubMed     Abstract available


  55. GARCIA P, Anand S, Han J, Montez-Rath M, et al
    COVID19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis.
    J Am Soc Nephrol. 2021 Oct 13. pii: ASN.2021070936. doi: 10.1681/ASN.2021070936.
    PubMed    


  56. LIOUFAS N, Pascoe E, Hawley C, Elder G, et al
    Systematic Review and Meta-analyses of Effects of Phosphate-lowering Agents in Non-dialysis Chronic Kidney Disease.
    J Am Soc Nephrol. 2021 Oct 13. pii: ASN.2021040554. doi: 10.1681/ASN.2021040554.
    PubMed     Abstract available


  57. NIU J, Saeed MK, Winkelmayer WC, Erickson KF, et al
    Patient Health Outcomes following Dialysis Facility Closures in the United States.
    J Am Soc Nephrol. 2021;32:2613-2621.
    PubMed     Abstract available


  58. DANZIGER J, Mukamal KJ, Weinhandl E
    Associations of Community Water Lead Concentrations with Hemoglobin Concentrations and Erythropoietin-Stimulating Agent Use among Patients with Advanced CKD.
    J Am Soc Nephrol. 2021;32:2425-2434.
    PubMed     Abstract available


    September 2021
  59. VAN PRAET J, Reynders M, De Bacquer D, Viaene L, et al
    Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study.
    J Am Soc Nephrol. 2021 Sep 29. pii: ASN.2021070908. doi: 10.1681/ASN.2021070908.
    PubMed     Abstract available


  60. GO AS, Tan TC, Chertow GM, Ordonez JD, et al
    Primary Nephrotic Syndrome and Risks of ESKD, Cardiovascular Events, and Death: The Kaiser Permanente Nephrotic Syndrome Study.
    J Am Soc Nephrol. 2021;32:2303-2314.
    PubMed     Abstract available


  61. BOUDHABHAY I, Delestre F, Coutance G, Gnemmi V, et al
    Reappraisal of Renal Arteritis in ANCA-associated Vasculitis: Clinical Characteristics, Pathology, and Outcome.
    J Am Soc Nephrol. 2021;32:2362-2374.
    PubMed     Abstract available


    August 2021
  62. SHEN CR, Jia XY, Luo W, Olaru F, et al
    Laminin-521 is a Novel Target of Autoantibodies Associated with Lung Hemorrhage in Anti-GBM Disease.
    J Am Soc Nephrol. 2021;32:1887-1897.
    PubMed     Abstract available


    June 2021
  63. MAYRDORFER M, Liefeldt L, Wu K, Rudolph B, et al
    Exploring the Complexity of Death-Censored Kidney Allograft Failure.
    J Am Soc Nephrol. 2021;32:1513-1526.
    PubMed     Abstract available


  64. LADIN K, Neckermann I, D'Arcangelo N, Koch-Weser S, et al
    Advance Care Planning in Older Adults with CKD: Patient, Care Partner, and Clinician Perspectives.
    J Am Soc Nephrol. 2021;32:1527-1535.
    PubMed     Abstract available


    May 2021
  65. RAMSPEK CL, Evans M, Wanner C, Drechsler C, et al
    Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD.
    J Am Soc Nephrol. 2021;32:1174-1186.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: